Arbor Research Collaborative for Health has been awarded a contract under the Centers for Medicare & Medicaid Services Research, Measurement, Assessment, Design, and Analysis 3 Indefinite Delivery/Indefinite Quantity contract, known as RMADA 3.

Arbor Research was one of 17 organizations selected from a highly competitive field of offerors for the RMADA 3 IDIQ. The award reflects CMS’ continued need for experienced, multidisciplinary partners capable of supporting complex health care payment and service delivery models with rigorous analytics, practical implementation support, and clear, actionable evidence.

Through this multiple-award vehicle, Arbor Research will be eligible to compete for future task orders supporting CMS and the CMS Innovation Center in the design, implementation, monitoring, evaluation, and improvement of health care payment and service delivery models through the IDIQ’s five-year period of performance.

RMADA 3 continues a long-standing area of CMS-funded work for Arbor Research. Arbor Research has served as an awardee under the original RMADA and RMADA 2 IDIQ vehicles and has supported multiple CMS Innovation Center models and task orders, including the Home Health Value-Based Purchasing Model, the End-Stage Renal Disease Treatment Choices Model, Kidney Care Choices, and other model implementation, monitoring, learning, and evaluation efforts.

“Arbor Research is honored to continue supporting CMS in work that sits at the center of evidence-based health care improvement,” said Christopher Spera, Chief Executive Officer of Arbor Research. “Being selected for RMADA 3 in a highly competitive procurement is a meaningful recognition of our team’s expertise, our record of performance, and our ability to help CMS generate evidence that is rigorous, timely, and useful.”

RMADA 3 is intended to provide CMS with analytic support and technical assistance for models and demonstration programs that test approaches to reducing expenditures for Medicare, Medicaid, CHIP, and uninsured beneficiaries while maintaining or improving quality of care. Task orders under the vehicle may include program, data, and environmental analyses; model implementation monitoring; primary and secondary data collection; formative and summative evaluation; rapid-cycle analytic feedback; stakeholder engagement and training; learning system support; technical assistance; and the development of reports, tools, templates, and educational materials.

The award is also a tribute to the Arbor Research staff and partners who contributed to the pursuit. Their work drew on deep institutional experience with RMADA and RMADA 2, recent performance supporting CMS Innovation Center models, and Arbor’s broader strengths in health services research, data analytics, quality measurement, stakeholder engagement, program evaluation, and technical assistance.

The RMADA 3 award positions Arbor Research to continue supporting CMS as it tests and assesses innovative care delivery and payment models, generates timely evidence, and translates findings into practical insights for federal decision-makers and the broader health care community.
“This is a proud moment for Arbor Research,” Spera said. “We are excited to build on our RMADA and RMADA 2 experience and bring our analytic depth, operational discipline, and collaborative approach to future RMADA 3 task orders.”